Is the new treatment for wet age related macular degeneration a good one?

Eylea (aflibercept)?: The newest treatment out for wet amd is called Eylea (aflibercept) (alfibercept). It's a drug that is injected into the eye. It has been very successful in my practice, particularly in patients who have failed other treatments.

Yes.: All the currently approved injections and even the use of the off label medication Avastin have been validated with very good clinical studies. To learn about comparison of Avastin to Lucentis (ranibizumab) see the caat trial. Eylea is also very effective. All work best in the early phase of wet macular degeneration. The use of one over the others depends on several factors. Ask your retinal specialist.

Promising: Age-related macular degeneration is a chronic disease of the central part of the retina. It is broken down into two types, the "dry" form, which involves slow, patchy deterioration of retinal cells, and the "wet" form which is caused by bleeding and leads to rapid vision loss. Current treatment for "wet" is intravitreal injections with eylea, lucentis, (ranibizumab) or avastin.